AbbVie, U of C Choose First Batch of Cancer Research Projects
Published on
Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include a new immunotherapy that could essentially weaponize a person’s immune system to fight tumors; the search for a drug to pair with traditional chemotherapy to treat neuroblastoma, an aggressive cancer that most often affects children; a combination of therapies for lung, head, neck and bladder cancers; and therapies that target prostate cancer for patients who are resistant to typical treatments. Read more.